FDA Drug Recalls

Recalls / Class II

Class IID-1048-2019

Product

Losartan Potassium Tablets, USP, 25 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-577-54

Affected lot / code info
Lots: 180952, exp Oct-19, 180953, exp Dec-19, 181086, exp Sep-19, 181572, exp Jan-20

Why it was recalled

CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected

Recalling firm

Firm
Legacy Pharmaceutical Packaging LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
13333 Lakefront Dr, N/A, Earth City, Missouri 63045-1514

Distribution

Quantity
456,732 bottles
Distribution pattern
Wal-Mart distribution centers in AR, CA, GA, IN and MD

Timeline

Recall initiated
2019-03-01
FDA classified
2019-03-21
Posted by FDA
2019-03-27
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-1048-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls